Literature DB >> 23659881

Baseline hypertension: new insight into the potential predictors of survival in patients with hepatocellular carcinoma.

Yu-Feng Hu1, Tzu-Chi Chen, Gar-Yang Chau, Tsung-Lin Yang, Chia-Jen Liu, Ming-Huang Chen, Peter Mu-Hsin Chang, Tzeng-Ji Chen, Michael Hsiao, Chi-Ying F Huang, Shih-Ann Chen.   

Abstract

Entities:  

Keywords:  Barcelona Clinic Liver Cancer stage; CRKL; Mortality; Predictive marker of HCC; VEGFR-1

Mesh：

Year:  2013        PMID： 23659881     DOI： 10.1016/j.ijcard.2013.04.106

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

1.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

2.  Influence of metabolic and other clinicopathologic factors on the prognosis of patients with hepatocellular carcinoma undergoing hepatic resection.

Authors:  Kui Sun Choi; Dong-Sik Kim; Sung Won Jung; Young-Dong Yu; Sung Ock Suh
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-11-30

3.  Increased Level of Systolic Blood Pressure in Hepatocellular Carcinoma Patients with Diabetes Mellitus.

Authors:  Wei-Shuo Zhang; Xiao-Ou Li; Hui Zhang; Chun Gao; Long Fang; Hua-Yuan Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-15       Impact factor: 3.168

Review 4.  Anticoagulation for atrial fibrillation in active cancer.

Authors:  Dimitrios Farmakis; Pavlos Papakotoulas; Eleni Angelopoulou; Theodoros Bischiniotis; George Giannakoulas; Panagiotis Kliridis; Dimitrios Richter; Ioannis Paraskevaidis
Journal:  Oncol Lett       Date:  2022-02-17       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.